Heat Biologics, Inc. Announces Closing of $13,800,000 Public Offering

Nov 26, 2018

Heat Biologics to Participate in Panel Presentation at the Goldman Sachs Asia Pacific Healthcare Forum

Nov 26, 2018

Heat Biologics, Inc. Prices $12,000,000 Public Offering

Nov 21, 2018

Heat Biologics, Inc. Announces Proposed Public Offering

Nov 20, 2018

Heat Biologics Reports Third Quarter 2018 Results and Provides Corporate Update

Nov 15, 2018

Heat Biologics to Present at Precision: Lung Cancer World R&D Summit

Oct 22, 2018

Heat Biologics CEO to Participate in Panel Presentation at The Cellular ''Living Drug'' Revolution Summit in New York City

Oct 19, 2018

Heat Biologics to Present at the 2018 BIO Investor Forum

Oct 10, 2018

Heat Biologics’ Pelican Subsidiary Provides Update on its Novel PTX-35 T-Cell Costimulator

Oct 4, 2018

Heat Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City

Aug 29, 2018